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ABSTRACT
Context: Origanum (Lamiaceae) has been used in food and pharmaceutical industries.
Objective: Isolation and identification of bioactive compounds from Origanum rotundifolium Boiss. and
investigation of their antiproliferative and antioxidant activities.
Materials and methods: The aerial part of O. rotundifolium was dried and powdered (1.0 kg ±2.0 g) then
extracted with hexane, ethyl acetate, methanol and water. Solvent (3 1 L) was used for each extraction
for a week at room temperature. The aqueous extract was partitioned with ethyl acetate (3 1 L) to yield
the water/EtOAc extract subjected to chromatography to isolate the active compounds. The structures of
isolated compounds were elucidated by 1D, 2D NMR and LC-TOF/MS.
Results: Apigenin (1), ferulic acid (2), vitexin (3), caprolactam (4), rosmarinic acid (5), and globoidnan A
(6) were isolated and identified. Globoidnan A (6), vitexin (3), and rosmarinic acid (5) revealed the excel-
lent DPPH scavenging effect with IC50 values of 22.4, 31.4, 47.2lM, respectively. Vitexin (3) (IC50 3.6), glo-
boidnan A (6) (IC50 4.6), apigenin (1) (IC50 8.9) and ferulic acid (2) exhibited more ABTS
þ activity than
standard Trolox (IC50 13.8lg/mL). Vitexin (3) revealed the most antiproliferative activity against HeLa,
HT29, C6 and Vero cells lines with IC50 values of 35.6, 32.5, 41.6, 46.7 (lM), respectively.
Discussion and conclusion: Globoidnan A (6) has the most antioxidant effects on all assays. This has to
do with the chemical structure of the compound bearing the acidic protons. Vitexin (3) could be a prom-
ising anticancer agent.
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Plants have played a significant role in drug discovery and devel-
opment process. In many nations, medicinal plants have been
the main source of primary healthcare. Nearly 80% of world
populations rely on folk medicine to treat various illnesses. The
bioactive secondary metabolites isolated from plants have consti-
tuted the drug discovery. Recently, there has been a significant
increase in the discovery of molecular targets that may be applied
to the discovery of novel materials for the diagnosis and treat-
ment of human diseases (Newman & Cragg 2007).
Due to the difficulty of synthesis, polyphenols, bioactive
natural products, play an important role in the human need to
satisfy their phenolic requirements through daily consumption
of fruits and vegetables. Phenolic compounds are effective in
the treatment of chronic and acute diseases such as cancer, car-
diovascular disorders and inflammation (Baiano et al. 2014).
Origanum (Lamiaceae) has 23 species and six hybrids in
Turkey flora, 14 of which are endemic (Baser 2002). Origanum,
widely used in food industry and traditional medicine in many
countries, is an important medicinal and aromatic plant (Wakim
et al. 2013). Origanum species have been consumed as a folk
medicine for treatment of sickness such as indigestion, headache,
muscle pains, diarrhoea, rheumatism, asthma as herbal tea
(Jun et al. 2001). A good deal of work has been carried out with
Origanum on the chemical composition of essential oils which
have been applied in flavouring of various foods, particularly sau-
ces, fish, soups, meat, canned foods and bitters (Busatta et al.
2008). In addition, this genus exhibits antimicrobial activity
against foodborne bacteria and fungi (El-Ashmawy et al. 2007).
This plant genus exhibits biological activities such as antioxidant
(Papageorgiou et al. 2008; Baatour et al. 2011), antiulcerogenic
(Al-Howiriny et al. 2009), antimicrobial (Kacaniova et al. 2014),
antiviral (Zhang et al. 2014), antinociceptive (Pahlavan et al.,
2013), antitumour (Thoppil et al. 2013; Tuncer et al. 2013) and
antifungal (Fadel et al. 2013). Previous phytochemical and
pharmacological studies on the Origanum have revealed the pres-
ence of monoterpenes (Exarchou et al. 2013), diterpenes (Takeda
et al. 2008), flavonoids (Lin et al. 2003), steroids (Bellakhdar
et al. 1988), hydroquinone, hydroquinone-monomethyl ether
(Assaf et al. 1987), flavone glycosides (Chatzopoulou et al. 2010)
and other pharmaceutically and medicinally valuable compounds
(Lin et al. 2003). Due to the biological and chemical diversities,
the demand of Origanum in the world market has increased
steadily. Turkey is the leading country for the production and
exportation of Origanum (Ozkan et al. 2010).
Free oxygen radicals, called reactive oxygen species (ROS),
comprising hydroxyl radical, superoxide and singlet oxygen, can
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yield cellular harm leading to diseases such as DNA damage
(Pelicano et al. 2009), cancer (Lambert & Yang 2003), cardiovas-
cular diseases (Diaz et al. 1997), Parkinson (Perfeito et al. 2012)
and Alzheimer’s disease (Rottkamp et al. 2000). Even though ROS
are formed by metabolic functions, they could be scavenged by
compounds existing in fruits, vegetables and herbs. Hence, the
extracts of fruits, vegetables and herbs containing most antioxi-
dant compounds are important for pharmacology and food indus-
try (Bae et al. 2012). Antioxidants, revealing significant effects for
health by reduction of the oxidative stress, are used to prevent
food from oxidative deterioration (Narita & Inouye 2012).
Therefore, natural and synthetic antioxidants are employed to
protect fresh food. Butylated hydroxytoluene (BHT), propyl gall-
ate (PG), butylated hydroxyanisole (BHA), tert-butylhdroquinone
(TBHQ) are commonly used as synthetic antioxidants. However,
due to the toxicity of these chemicals, demand for natural antioxi-
dants has increased steadily (Liu et al. 2011). Natural antioxidants
also have diverse biological effects such as antiviral, antiinflamma-
tory, antithrombotic, antibacterial and vasodilatory activities
(Cook & Samman 1996).
Cancer is a major health problem and is the second leading
cause of death worldwide. As reported by World Health
Organization (WHO) assessment, by 2050, 17.5 million cancer
deaths will have occurred in the world. The current chemothera-
peutic drugs are highly toxic, expensive and activate the alterna-
tive cell signaling pathways. Therefore, they have limited
therapeutic success in cancer (Khan et al. 2015). Cancer chemo-
prevention by natural products has appeared as a promising and
efficient approach to curtail the cancer risk and has gained great
interest since it is regarded as safe, cheap and complementary
medicine to current healthcare system (Khan et al. 2016). Plants
have been used in the treatment of cancer for years and have
gained the importance to be most attractive source of anticancer
drugs. The secondary metabolites such as alkaloids and polyphe-
nols isolated from plants have been reported for their anticancer
activities (Onrubia et al. 2013).
In this work, secondary metabolites were isolated by chroma-
tographic techniques and structures of isolated compounds were
elucidated by spectroscopic methods. Antiproliferative effects and
antioxidant activity of isolated compounds are presented.
Materials and methods
General experimental procedures
NMR spectra were recorded on a spectrometer operated at
400MHz for 1H and 100MHz for 13C NMR. Chemical shifts
were given in ppm (d scale), coupling constant (J) in Hz.
Column chromatography was performed on silica (60–230 mesh,
Merck). TLC was carried out on analytical alumina plates (60
F254). Hitachi U-290 UV-Vis spectrometer was used for UV
measurements. HRMS analyses were recorded on Agilent 6210
LC-TOF/MS spectrometer. Ammonium thiocyanate and BHT
were purchased from E. Merck (Darmstadt, Germany). Ferrous
chloride, BHA and trichloracetic acid (TCA), formic acid, foetal
bovine serum (FBS), penicillin/streptomycin and Dulbecco’s
modified Eagle’s medium-high glucose (DMEM-HG) were pur-
chased from Sigma-Aldrich (Darmstadt, Germany).
Plant material
The plant materials were collected from Artvin, east part of
Turkey during the flowering period in July 2014 and identified
by Prof. Dr Ozgur Eminagaoglu, specialists of Plant Taxonomy
at Department of Forestry Engineering, Faculty of Forestry,
Artvin Coruh University where a voucher specimen was depos-
ited (No: ARTH 5247). The O. rotundifolium was dried in shade,
finely powdered for extraction process.
Extraction and isolation
Origanum rotundifolium aerial part was dried and powdered
(1.0 kg ±2.0 g) then extracted with hexane (3 1 L) for a week at
room temperature, filtered and solvent was removed to obtain
hexane extract. Solid material of hexane extract was re-extracted
with ethyl acetate (3 1 L) for a week at room temperature, fil-
tered and after removal of the solvent, ethyl acetate extract was
achieved. Methanol extract was acquired by extracting (3 1 L)
the solid part of ethyl acetate extract for a week at room tempera-
ture. The solid part of methanol extract was heated with distil-
lated water (500mL) at 80 C for 2 h, filtered then 100mL of
which was lyophilized to get the water extract. The other part of
the water extract (400mL) was partitioned with ethyl acetate, and
ethyl acetate phase was separated by separator funnel, dried with
(MgSO4), filtered then solvent was removed to obtain the water/
ethyl acetate extract revealing the most antioxidant activity and
including the highest phenolic contents. Therefore, chromato-
graphic techniques were applied for water/EtOAc extract to isolate
the bioactive compounds. The water/EtOAc extract (14 g) was
subjected to silica gel column chromatography (100 2.5 cm),
eluted with a solvent system with increasing polarity from hexane
to EtOAc and EtOAc-MeOH. 400 fractions, each 100ml were col-
lected. After checking the thin-layer chromatography, the com-
pounds having same Rf values were combined. Apigenin (1) was
isolated from the fractions of 154–182 with further purification of
silica gel column chromatography. The fractions 183–188
included the ferulic acid (2). 190–220 fractions were combined
and chromatographed on silica gel to isolate vitexin (3).
Caprolactam (4) was isolated as pure form from fractions
230–260. Rosmarinic acid (5) was isolated from the fractions
300–330. The fractions 340–400 were combined and subjected to
column chromatography to isolate the globoidnan A (6).
Antioxidant assays
Determination of total phenolic compounds
Gallic acid and Folin–Ciocalteu reagent were used to determine
the total phenolic constituent of extract (Slinkard & Singleton
1977). Stock solution was prepared by dissolving the extract
(1.0mg) in MeOH (1.0mL). An aliquot of stock solution (0.1mL)
was added to test tube then deionized water (4.5mL), a solution
of Folin-Ciocalteu reagent (0.1mL) and Na2CO3 (0.3mL, 2%)
were added. After stirring 3min vigorously, the mixture was kept
for 2 h incubation. The absorbance measurement was carried out
at 760 nm in a spectrophotometer. The total phenolic constituents
concentrations in the extracts were calculated as gram of gallic
acid equivalent by using the below equation.
Absorbance ¼
1:018 Total phenols Gallic Acid Equivalent mgð Þ
 0:001
DPPH scavenging assay
The free radical scavenging activities of extracts and standards
were evaluated by 2,2-diphenyl-1-picrylhydrazil (DPPH)
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(Blois 1958). To a different concentration of 3.0mL of extract
(3.0–20 lg/mL) in ethanol, DPPH solution (1.0mL, 0.26mM)
were added. After that it is stirred and kept at Rt for 30min, The
absorbance of the mixture was executed at 517 nm in a spectro-
photometer. The activity was calculated by the below equation.




In which, Ac and As are the control and sample absorbance,
respectively.
ABTSþ scavenging assay
2,200-Azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) cat-
ion radical scavenging assay based on the decreasing ABTS radical
cation, a blue/green chromophore with absorption at 737 nm, in
comparison to that of BHA, BHT and Trolox. This method was
executed as in the literature (Re et al. 1999). Treatment of ABTS
(2.0mM) in phosphate buffer (0.1M, pH 7.4) with potassium per-
sulfate (K2S2O8) (2.45mM) gave the ABTS
þ, kept at dark at Rt
for 4 h. Initially, dilution of ABTSþ was performed with sodium
phosphate buffer (pH 7.4, 0.1M) to obtain absorbance
0.750 ± 0.025 at 734 nm. After all, ABTSþ solution (1.0mL) was
added to each extract solution in ethanol (3.0mL) at different con-
centration (2.5–20 lg/mL). After 30min, the inhibition was calcu-
lated for each concentration relative to a blank absorbance. The
scavenging ability of ABTSþ was calculated by given equation:
ABTSþscavenging activity %ð Þ ¼ Ac – Asð Þ=Ac   100 in
which, Ac is the initial concentration of ABTSþ and As is the
absorbance of the remaining concentration of ABTSþ in the
samples.
Ferric ions (Fe3þ) reducing antioxidant power assay (FRAP)
Different concentrations of samples (5–40 lg/mL) in 1mL of
deionized water were mixed with sodium phosphate buffer
(1.25mL, 0.2M, pH 6.6) and potassium ferricyanide [K3Fe(CN)6]
(1.25mL, 1%). After the incubation of the mixture at 50 C for
20min, trichloroacetic acid (1.25mL, 10%) and FeCl3 (0.25mL,
0.1%) were added to the reaction medium. The reaction mixture
was vortexed thoroughly and absorbance measurement at 700 nm
was executed in a spectrophotometer. Increase in the absorbance
reveals the increase in the reduction capability of the reaction
mixture (Oyaizu 1986).
Antiproliferative assays
Preparation of cell culture
Anticancer potential of isolated compounds was investigated on
C6, HT29, HeLa and Vero cell lines. These cells were sustained
with Dulbecco’s modified eagle’s medium, complemented with
foetal bovine serum and PenStep solution (ATCC, American
Type Culture Collection). The old medium was aspirated out of
the plate while cells had reached a confluence of 80% then cells
were removed from the flasks using trypsin-EDTA (4mL) and
centrifuged. Afterward, cell pellet was suspended with DMEM
and was counted to gain a final concentration as 5 104 cells/mL,
inoculated into wells (100 lL cells/well).
Cell proliferation assay
The antiproliferative activity of compounds against various cell
lines (C6, HeLa and Vero cells) was tested by cell proliferation
assay using BrdU Cell Proliferation ELISA kit. A cell suspension
containing nearly 5 103 cells in 100lL was conveyed into the
well cell plates (96-well cell). The treatments of cells with com-
pounds in DMSO and 5-Florouracil (5 FU) in DMSO separately
at concentration 5–100lg/mL were carried out. The last volume
of the wells was adapted to 200lL by DMEM and mixture was
incubated at 37 C with 5% CO2 for overnight (Okten et al.
2013).
IC50 and % inhibition
The half inhibitory concentration of the isolated compounds and
standards was calculated by XLfit5 software (IDBS) and expli-
cated in lM at 95% confidence levels (Table 1). The proliferation
results were recorded as the per cent inhibition of the com-
pounds and control substances. The following formula was used
for the calculation of inhibition
% Inhibition ¼ Asample– Acontrol=Acontrol
  100
where Asample is the absorbance of the compounds and Acontrol is
the absorbance of the DMSO.
Cytotoxicity assay
The cytotoxicity of isolated compounds and standard on C6,
HT29, HeLa and Vero cells was presented through a Lactate
Dehydrogenase (LDH) Cytotoxicity Detection Kit (Roche, USA).
Almost 5 103 cells in 100 lL were seeded into 96-well microtiter
plates and treated with 5, 10, 20, 30, 40, 50, 75 and 100lg/mL
concentrations of these compounds at 37 C with 5% CO2 over-
night. LDH activity was executed by evaluating the absorbance at
492–630 nm by a microplate reader.
Statistical analysis
Statistical analyses were performed using the Statistical Package
for Social Sciences (Windows version 21.0: SPSS). Data were
reported as mean ± standard deviation. Between-group statistical
differences for parametric data were analyzed using the Student’s
t test or Duncan’s Multiple-Range Test was used. p< 0.05 was
considered as significant for all the tests.
Results and discussion
Natural products
After a series of column chromatography, apigenin (1) was isolated
as white powder. The 13C NMR spectrum and also DEPT experi-
ments showed 15 signals containing seven methines, seven quater-
nary carbon atoms and one carbonyl carbon that complied with
Table 1. IC50 values and tumour specificity rate for compounds.
IC50 (lM) Tumour specificity
Compounds HeLa HT29 C6 Vero HeLa HT29 C6
1 ND ND ND ND – – –
2 402.63 411.73 314.19 472.77 1.17 1.15 1.50
3 35.57 32.49 41.60 46.70 1.31 1.43 1.12
4 ND ND ND ND – – –
5 232.80 261.85 251.47 279.35 1.19 1.07 1.11
6 140.07 136.33 169.01 ND – – –
Cisplatin 44.25 48.58 61.45 40.78 0.92 0.84 0.66
ND: not determined.
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the structure. In 1H NMR spectrum, observation of signals at d
7.95 (d, J¼ 8.8Hz, H60), d 7.93 (d, J¼ 8.8Hz, H20), d 6.94 (d,
J¼ 8.8Hz, H30, H50), d 6.50 (d, J¼ 1.8Hz, H8), d 6.18 (d,
J¼ 1.8Hz, H6) accorded with the compound (Owen et al. 2003).
Ferulic acid (2) was isolated as white solid. The 13C spectrum
revealing the presence of one methoxy, five methines, three quater-
nary carbons and one carbonyl carbon suited with the structure. In
1H NMR spectrum, the signal observed at d 3.81 as singlet
belonged to methoxy group. The double bond protons’ signals at d
7.46 (H8) and d 6.36 (H7) with large coupling constant (J¼ 16.0)
revealed the linkage of acrylic acid to the phenyl moiety with trans
manner. The signals appeared at d 7.27 as a broad singlet belonged
to the H6. H2 and H3 proton resonated at d 7.06 and 6.78 with 8.0
coupling constant, respectively (Durust et al. 2001). Vitexin (3)
(Wen et al. 2007), caprolactam (4) (Dahlhoff et al. 2001), rosmar-
inic acid (5) (Erenler et al. 2016a), globoidnan A (6) (Erenler et al.
2016b) were isolated successively (Figure 1). Their structures were
elucidated by spectroscopic techniques basically 1D NMR, 2D
NMR, LC-TOF/MS and comparison of which with those reported
in the literatures. All spectra of isolated compounds were given as
Supplementary material.
Total phenolic contents
In this work, effective extraction method was developed by a ser-
ies of extraction techniques to yield the strong antioxidant activ-
ities. Interestingly, the total phenolic content of water/EtOAc
extract consists of four times as much as phenolic compounds
than the methanol extract which is the second one. This also led
to the best antioxidant activities. The order of total phenolic con-
tent is as follows: gallic acid/kg extract, water/EtOAc extract
(620.5)>MeOH extract (164.7)>water extract (134.6)>EtOAc
extract (44.9)> hexane extract (21.9).
DPPH free radical scavenging activity
The mechanism of DPPH scavenging activity is based on the
hydrogen or electron releasing capability of antioxidant molecules
to DPPH molecules to form the nonradical DPPH-H and the
measurement of the reducing ability of antioxidants. When
DPPH radicals react with a proton donor molecule like an anti-
oxidant, the radicals are scavenged and the absorbance is
reduced. During the reduction process, purple DPPH changes to
a colourless diphenyl picrylhydrazine and remaining DPPH
exhibiting the maximum absorption at 517 nm is measured
(Gulcin 2012). In this work, water/EtOAc extract exhibited the
best DPPH scavenging activity. Therefore, bioactive compounds
were isolated from this extract. The isolated compounds bearing
acidic protons revealed the excellent antioxidant activity. The
order of DPPH free radical scavenging activity is as follows
(lM): BHA (IC50 12.9)> globoidnan A (6) (IC50 22.4)>Trolox
(IC50 17.3)> vitexin (3) (IC50 31.4)> rosmarinic acid (5)
(IC50 47.2)> ferulic acid (2) (IC50 64.3)> apigenin (1)
(IC50 173.4)>BHT (IC50 196.1)> caprolactam (4) (IC50 328.8)
(Figure 2). Globoidnan A (6) has carboxylic acid group, hence it
can donate the proton to the DPPH radical easily and bearing
the hydroxyl groups of Globoidnan A (6) also facilitates the pro-
ton donation. Therefore, this compound revealed the excellent
DPPH scavenging activity.
ABTS radical cation decolourization assay
In this assay, ABTS is oxidized to its radical cation form, ABTS_þ
which is blue–green coloured. The antioxidant ability of extracts
and compounds is measured by detecting the decreasing colour
due to the reaction of extracts with ABTS_þ. Water/EtOAc extract
revealed the most ABTS radical cation activity among the
extracts. The order of activity of isolated compounds is as fol-
lows: vitexin (3) (IC50 3.7)> globoidnan A (6) (IC50 4.6)>BHT
(IC50 5.0)>BHA (IC50 7.6)> apigenin (1) (IC50 8.9)> ferulic
acid (2) (IC50 12.6)>Trolox (IC50 13.8)> rosmarinic acid (5)
(IC50 14.2)> caprolactam (4) (IC50 61.5) (Figure 2). Vitexin (3)
activity is close to globoidnan A one. The active compounds bear
protons to give to the ABTS_þ. This spectrophotometric technique
is easy and simple for screening and routine analyses. This
method is based on the inhibition of ABTS_þ by abstracting pro-
ton or electron from antioxidants. ABTS_þ is more reactive than
DPPH. ABTS radical scavenging method is applicable in a wide
pH range that is essential for food analysis (Gulcin 2012).
Reducing power
Reduction of Feþ3 to Feþ2 is determined by measuring the
absorbance of Perl’s Prussian blue complex (Gulcin 2009). The
reduction capacity of extract exhibits that it has a significant











































































Figure 1. Isolated compounds from O. rotundifolium.
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able to donate electrons to radicals which are reduced to more
stable and unreactive species. The reducing power of extracts was
investigated by Feþ3 to Feþ2 transformation assay. Ferric reduc-
tion powers of isolated compounds were given in Figure 2 and
results were compared to BHT, BHA and Trolox. Globodnin A
had higher activity than BHT, BHA and Trolox. The differences
were statistically significant (p< 0.05). The reducing power of
isolated compounds decreases in the following order (10 lg/mL):
globoidnan A (6) (1.25)>BHA (1.12)>BHT (0.81)> ferulic acid
(2) (0.67)>Trolox (0.61)> rosmarinic acid (5) (0.60)> vitexin
(3) (0.27)> apigenin (1) (0.14)> caprolactam (4) (0.08).
Activity of compounds against C6 (rat brain tumour) cell
lines
Vitexin (3) revealed the highest activity on C6 cells lines (lM,
IC50, 41.6) than the tested compounds including cisplatin (IC50,
61.5). Rosmarinic acid (2) and globoidnan A exhibited moderate
activity with IC50 values of 251.5 and 169.0 lM, respectively.
Noticeable effect has not been detected for apigenin (1) and capro-
lactam (4) on C6 cells lines. The extract activity was better than
the standard. This may be either the synergic effect of compounds
in the extract or consisting of active compound (Figure 3).
Activity of compounds and extract against HeLa (human
cervix carcinoma) cell lines
The isolated compounds and extract was evaluated against HeLa
cell lines at various concentrations. Apigenin (1) did not reveal
the noticeable activity whereas, vitexin (3) (IC50, 35.6) and ferulic
acid (2) (IC50, 40.6), showed the higher activity than the standard
(IC50, 44.3). Rosmarinic acid (5) (IC50, 232.8), globoidnan A (6)
(IC50, 140.1) displayed more or less activity than the
5-Florourasil at concentration dependence (Figure 3). The out-
standing activity of extract may be due to the synergic effect of
compounds into the extract.
Activity of compounds and extract against HT29 (human
colon carcinoma) cell lines
Apigenin (1) has not a noteworthy effect but vitexin (3) (IC50,
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Figure 2. DPPH scavenging, ABTSþ scavenging and reducing power activities of isolated compounds and positive controls. (The same letters on the columns of
DPPH and ABTS revealed that the differences are not significant statistically (p> 0.05). The different letters indicated that the differences are significant (p< 0.05).
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(IC50, 261.9) revealed the slightly activity between the concentra-
tions of 5–30 lg/mL but after this concentration the activity
increased sharply. While globoidnan A (6) (IC50, 136.3)
showed the good activity, the extract exhibited excellent activity
(Figure 3).
Activity of compounds and extract against vero (African
green monkey kidney epithelium) cells lines
The activity tests of isolated compounds and extract were exe-
cuted on Vero cell lines as well and similar trend was observed
on this cell lines. Ferulic acid (2) and vitexin (3) were effective at
high concentrations. Rosmarinic acid (5) and extract have good
effect on this cell lines but apigenin (1) caprolactam (4) glo-
boidnan A (6) did not reveal the remarkable activity (Figure 3).
The isolated compounds did not reveal the significant toxicity on
all cell lines.
Conclusions
Origanum rotundifolium is an important aromatic and medicinal
plant including significant bioactive compounds. Apigenin (1),
ferulic acid (2), vitexin (3), caprolactam (4), rosmarinic acid (5),
globoidnan A (6) were isolated from this plant by chromato-
graphic methods and structures of these compounds were eluci-
dated by spectroscopic techniques. These compounds exhibited
Figure 3. The antiproliferative activity of compounds on C6, HeLa, HT29 and Vero cell lines. Cell proliferation was measured using a BrdU Cell Elisa Assay Kit. Percent
inhibition was reported as mean values ± SEM of three independent assays (p< 0.05). Each experiment was repeated three times for each cell line.
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the excellent antioxidant activities. Moreover, ferulic acid (2),
vitexin (3), rosmarinic acid (5), globoidnan A (6) and extract
revealed the good antiproliferative activity on C6 (rat brain
tumour), HeLa (human cervix carcinoma), HT29 (human colon
carcinoma) and Vero (African green monkey kidney epithelium)
cells lines. The isolated compounds and extract of O. rotundifo-
lium has the potency to be used in food industries as a natural
antioxidant as well as pharmaceutical trades. These compounds
were isolated from O. rotundifolium for the first time.
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